107 results
Page 3 of 6
8-K
zapgupdrk9tcb7cue 1t
1 Dec 20
Departure of Directors or Certain Officers
8:05am
8-K
EX-99.1
8u08 6o7bdzvx
5 Nov 20
FibroGen Reports THIRD Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
pzsyhng46o3k82hrm
6 Aug 20
FibroGen Reports SECOND Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
mvnmkm5c492wj j0b
7 May 20
FibroGen Reports First Quarter 2020 Financial Results
4:09pm
S-3ASR
th4r5b118lj42uxlo c8
2 Mar 20
Automatic shelf registration
5:30pm
8-K
EX-99.1
93oadqlrz0wd6vvd
2 Mar 20
FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results
4:06pm
8-K
EX-99.1
x4s4251ag v54p
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
nrjyva8
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
v6t2yeudvhifam
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.2
mflh3wrsxxo
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am